Previous Article | Next Article ![]()
Infection and Immunity, October 1999, p. 5315-5323, Vol. 67, No. 10
Department of Microbiology and Immunology,
The University of Adelaide, Adelaide, South Australia, Australia 5005
Received 15 March 1999/Returned for modification 11 May
1999/Accepted 7 July 1999
Interleukin-5 (IL-5) transgenic mice are highly resistant to
primary infections with the intestinal nematode Nippostrongylus brasiliensis; few parasites are found in the intestines of
infected animals, and egg production is minimal. While adult worms may be damaged in the intestine, larval migration, development, and viability may also be impaired in other tissues. This study addresses the migration of N. brasiliensis larvae through the skin
and lungs and associated cellular responses in primary infections of
IL-5 transgenic mice. Although some larvae may have been trapped and killed in the lungs of IL-5 transgenic mice, most apparently failed to
reach this site. Two or more hours after infection of IL-5 transgenic
mice, eosinophils were a major component of the cellular infiltrate at
the subcutaneous site of injection, and localized eosinophil
degranulation was extensive. Seventy-five to ninety-five percent of the
larvae injected into subcutaneous air pouches in IL-5 transgenic mice
were retained there for at least 24 h. In contrast, in
nontransgenic mice, less than 20% of larvae could be recovered from
the skin 2 or more h postinjection, and eosinophil activity was modest
at all times. The data strongly suggest that eosinophils can restrict
the movement of N. brasiliensis larvae in the first few
hours of a primary infection and that this has profound effects on
later stages of parasite development. Preexisting eosinophilia, due
either to allergy or to infection with tissue-invasive helminth
species, may therefore confer some degree of immediate and nonspecific
resistance in primary infections with parasitic worms.
Eosinophils are polymorphonuclear
granular leukocytes produced within the bone marrow and normally
represent only a small proportion of leukocytes found in blood and most
tissues. Accumulation of eosinophils (eosinophilia) in peripheral blood
and tissues is considered a hallmark of many tissue-invasive helminthic
infections. In some geographical localities, eosinophilia is present in
a very large proportion of the human population (35).
Eosinophilia is associated with absence of reinfection of children with
Schistosoma species (15, 34), and atopy, which
often includes eosinophilia, has been associated with increased
resistance to helminth infections (14). Eosinophils can kill
a range of helminth species in vitro (2), and major basic
protein, which represents a large proportion of protein in eosinophil
granules, is highly toxic in vitro for schistosomula (3),
Trichinella spiralis (16), and Trypanosoma cruzi (19). Other eosinophil granule proteins such as
eosinophil peroxidase (EPO), eosinophil cationic protein, and
eosinophil-derived neurotoxin are also toxic for a number of parasites
(12, 17, 22). Such findings therefore suggest a major role
for eosinophils in protection against helminths and possibly in other
parasitic infections.
The cytokine interleukin-5 (IL-5) is a growth and differentiation
factor crucial to the regulation of eosinophilia. Constitutive expression of IL-5 transgenes induces lifelong eosinophilia in mice
(9). IL-5 transgenic mice are no more resistant than
nontransgenic littermates to several helminth species (6, 8,
32), but they do show greater resistance to the intestinal
nematode Nippostrongylus brasiliensis (6, 7).
Arrival of adult N. brasiliensis worms into the small
intestine is delayed in IL-5 transgenic mice relative to nontransgenic
mice. In addition, fewer parasites survive passage through the usual
migratory pathway from the subcutaneous inoculation site to the small
intestine (6, 7). Surviving worms recovered from the small
intestines of IL-5 transgenic mice exhibit reduced fecundity, fail to
grow, and are less likely to occupy the preferred site of attachment in
the anterior section of the small intestine (7). Such
findings suggest that while parasite growth and development may be
adversely affected in the small intestines of IL-5 transgenic mice, it
is also likely that migration and maturation of N. brasiliensis larvae is inhibited prior to the intestinal stage of
the life cycle. To address this possibility, we examined the migration of N. brasiliensis larvae from a subcutaneous inoculation
site to the lungs and analyzed the inflammatory response induced in both sites. Our data suggest that the entrapment and killing of larvae
begin within a few hours of initiation of a primary infection in IL-5
transgenic mice and that this process is likely to be mediated by
eosinophils. It is possible that eosinophils have a previously
unrecognized role to play in primary resistance to any of a number of
helminth infections in humans, a matter worthy of consideration when
new therapies designed to regulate the putative actions of eosinophils
are applied in cases of asthma and allergy.
Animals.
Female heterozygous IL-5 transgenic (Tg5C2) CBA
mice, carrying approximately 49 copies of the transgene (9),
and their normal littermates were bred in the University of Adelaide
Medical School Animal House. The immunology and parasite biology
characteristics of these mice have been described previously
(6-8, 31, 32). All mice were closely aged matched within
experiments. Hooded Wistar (randomly bred) and dark agouti rats
(inbred) produced by Laboratory Animal Services at the University of
Adelaide were used for passage of N. brasiliensis. Animals
were handled according to Animal Ethics Committee guidelines of the
University of Adelaide.
Parasitological techniques.
Infective N. brasiliensis third-stage larvae (L3) were obtained by the fecal
culture method, washed twice in saline, and injected subcutaneously
(s.c.) or into air pouches at an approximate dose of 500 larvae per
mouse. At designated time points following infection, mice were
sacrificed by CO2 asphyxiation. Whole lungs were removed, finely minced, and incubated in saline at 37°C for at least 2 h
before emergent larvae were enumerated under a dissecting microscope.
Histology.
Lungs were inflated and fixed in situ by tracheal
infusion of 10% buffered formalin before removal and further fixation
in the same solution. Five-micrometer-thick sections of
paraffin-embedded tissues were stained with hematoxylin and eosin
(H&E.) and evaluated by light microscopy. The shaved skin together with
the underlying fat pad at the site of injection of L3 were removed,
pinned to a cork board fur side down, fixed in 10% buffered formalin,
and processed as described above.
Generation of air pouches.
Air pouches were formed as
described previously (11), with modifications. Briefly, 2.5 ml of sterile air was injected s.c. into a shaved skin site on the back
of each mouse. This was allowed to settle for 3 days to permit healing
of the wound. The pouch was then reinflated with 2 ml of sterile air
and left for a further 3 days before injection of either 500 N. brasiliensis L3 in 1 ml of endotoxin-free phosphate-buffered
saline (PBS) or PBS alone. All air pouch procedures were conducted
under light ether anesthesia. Mice were sacrificed by CO2
asphyxiation, and the pouches were lavaged with 1 ml of mouse
osmolality PBS (MPBS), followed by two separate washes with 2 ml of
MPBS for each. Pouch washings were centrifuged at 100 × g
for 10 min before enumeration of total and viable cells by using trypan
blue exclusion and a hemocytometer. Supernatants were snap frozen for
analysis of EPO. The number of larvae recovered was estimated from a
sample of the resuspended pellet. Pouch exudate cells were
cytocentrifuged onto glass slides, air dried, fixed with methanol, and
stained with Giemsa (BDH Chemicals, Gurr, Australia). Differential cell
counts were estimated by enumeration of a minimum of 200 cells per sample.
Measurement of EPO.
EPO was measured in lungs and washings
from air pouches by using a modification of techniques described
previously (10, 33). Whole lungs were removed immediately
following death, homogenized in MPBS in a mechanical homogenizer
(Ultra-Turrex), and subjected to three cycles of freezing and thawing.
EPO activity was determined in fluid phase by oxidation of
o-phenylene diamine (OPD Sigma Fast tablets; Sigma, St.
Louis, Mo.) in the presence of hydrogen peroxide. Samples were run in
duplicate with and without resorcinol (1.5 mg/ml; Sigma), an eosinophil
peroxidase-specific inhibitor, to differentiate EPO from neutrophil and
macrophage myeloperoxidases (27, 29). Absorbance of the
reactions was measured with a Biolumin-960 plate reader and Xperiment
software (Molecular Dynamics Inc, Sunnyvale, Calif.). Absorbance values
with resorcinol were subtracted from those without the inhibitor to
estimate the level of EPO activity. Results are expressed as mean
arbitrary absorbance units at 490 nm ± standard error of the mean (SEM).
Statistics.
Where appropriate, data were analyzed by
two-tailed Student's t test using Excel for Macintosh 4.0 (Microsoft), with P < 0.05 considered significant.
Recovery of larvae from lungs.
N. brasiliensis larvae
migrate from the skin to the lungs, where they undergo a molt and
maturation phase en route to the small intestine (18). In
secondary infections in nontransgenic mice, larvae appear to be
surrounded by eosinophil-rich leukocyte infiltrates in the lungs
(36). To determine whether the lungs might also be a site of
entrapment and killing of larvae in primary infections in IL-5
transgenic mice, we assessed lung larval burdens from 10 to 84 h
postinfection (p.i.).
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Trapping and Immobilization of
Nippostrongylus brasiliensis Larvae at the Site of
Inoculation in Primary Infections of Interleukin-5 Transgenic
Mice
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (27K):
[in a new window]
FIG. 1.
Recovery of N. brasiliensis larvae from the
lungs of nontransgenic and Tg5C2 IL-5 transgenic mice following primary
infection with 500 infective larvae. Nontransgenic mice exhibited a
significantly higher parasite burden than similarly infected IL-5
transgenic mice. Each bar represents the mean number of larvae
recovered ± SEM from three to seven mice per group. *,
significantly different from nontransgenic littermates at the same
stage of infection; P
0.01.
Eosinophil responses in the lungs. Twenty-four hours p.i. larvae could be detected in histological sections of lungs recovered from both nontransgenic and IL-5 transgenic mice (Fig. 2A and B), though as indicated above, they were relatively rare in the latter. Many erythrocytes could be found in the immediate vicinity of larvae, in keeping with the hemorrhagic foci seen macroscopically on the surfaces of the lungs. At this stage of the infection, eosinophils were not prominent in the lungs of either nontransgenic or transgenic mice. Those leukocytes which were present were mostly mononuclear cells, many of which appeared to be macrophages. However, by 60 h p.i., substantial eosinophil-rich infiltrates were observed in the lungs of both host types (Fig. 2C and D). In nontransgenic mice, eosinophils became obvious only after most larvae had left the lung (Fig. 2C), whereas in IL-5 transgenic mice, the presence of large numbers of eosinophils in lung sections was approximately coincident with the later appearance of lung-stage larvae. Sixty hours p.i., some parasites detected in sections of lungs from transgenic mice were surrounded by large inflammatory infiltrates (Fig. 2D); 6 days p.i., very large granulomatous structures, which were apparently free of larvae, were found (data not shown).
|
|
Detection of larvae and eosinophilic infiltrates in subcutaneous tissue. Larval migration to the lungs of IL-5 transgenic mice is clearly inhibited compared to that in nontransgenic controls, suggesting entrapment and/or killing of the parasite prior to this stage of the life cycle. The subcutaneous inoculation site was analyzed, since it is the first site at which larvae are localized in the host. Cellular infiltrates composed principally of eosinophils were observed to surround larvae in skin from both nontransgenic and IL-5 transgenic mice from as early as 2 h p.i. However, many more leukocytes, and especially eosinophils, were evident in the latter (Fig. 4A and B). Larvae were identified infrequently at the inoculation site at times later than 6 h p.i. in nontransgenic mice (Fig. 4C, 24 h p.i.). Both eosinophil-rich leukocyte infiltrates and larvae were detected for at least 48 h after infection at the site of inoculation in IL-5 transgenic mice (Fig. 4D, 24 h p.i.).
|
Quantitation of leukocytes and larvae in air pouches. To quantitate and further characterize the early leukocyte response to N. brasiliensis, L3 were injected into air pouches raised in the dorsal skin. No more than a mean of 2 × 105 cells were recovered from air pouches in nontransgenic mice injected only with endotoxin-free PBS (maximum detected 4 h p.i., compared to 6 × 104 cells for uninjected air pouches) and of these, 40% were neutrophils and 10% were eosinophils. Injection of endotoxin-free PBS alone into air pouches raised in IL-5 transgenic mice induced a significant increase in the cellular infiltrate by 2 h p.i., and this reached maximum levels at 4 h p.i. (mean of 2 × 106 leukocytes/pouch; 25% neutrophils, 53% eosinophils). This number of cells was significantly higher than the mean of 3 × 105 cells/pouch (22% neutrophils, 55% eosinophils) recovered from uninjected transgenic mice.
Two hours after injection of larvae, total leukocyte numbers in air pouches rose dramatically in both nontransgenic and IL-5 transgenic mice (Fig. 5A). Total air pouch leukocyte counts of both nontransgenic and transgenic mice infected for 2 or more h were always at least threefold higher than values from mice injected with PBS alone (full data not shown). From 2 to 32 h p.i., at least three- to fivefold more cells were recovered from air pouches in IL-5 transgenic mice injected with larvae than from pouches in similarly treated nontransgenic hosts (Fig. 5A). The presence of large numbers of neutrophils was noted in the first 2 h of infection in both lines of mice. In nontransgenic animals, neutrophil numbers peaked 4 to 12 h p.i. (Fig. 5B) and remained at approximately 80% of total leukocytes until at least 48 h p.i. Eosinophils also became more numerous in air pouches in nontransgenic mice from 2 h p.i., and numbers peaked 4 to 24 h p.i. However, eosinophils never represented more than 10% of the total leukocytes recovered from air pouches in nontransgenic mice (Fig. 5C). The numbers of eosinophils recovered from air pouches in transgenic mice 2 h after injection of larvae were approximately 5-fold higher than those from PBS-injected IL-5 transgenic mice (full data not shown) and 20-fold higher than those from pouches in nontransgenic mice infected with larvae for the same period of time (Fig. 5C). Peak eosinophil numbers were observed 4 to 12 h p.i. in IL-5 transgenic mice, declining gradually thereafter but nevertheless remaining significantly greater than those in nontransgenic animals for at least 32 h p.i. (Fig. 5C). Relatively few lymphocytes were detected in air pouches at any time point in either transgenic or nontransgenic mice infected with the parasite (range of 1 to 3% of total leukocytes [data not shown]). Monocyte numbers in the air pouches of parasite-infected IL-5 transgenic mice were higher than those in the air pouches of infected nontransgenic mice between 12 and 32 h p.i. (e.g., 1.9 × 106 and 9 × 104 respectively at 32 h PI; P < 0.02 [data not shown]).
|
|
Retention of larvae in air pouches. Retention of larvae within air pouches was monitored over a 48-h period (Fig. 7). In both transgenic and nontransgenic hosts, almost 100% of the estimated dose was recoverable when air pouches were washed out immediately following injection. At all other time points assessed, larval recovery was greater from air pouches in transgenic mice than from those in nontransgenic littermates. From 2 to 24 h p.i., only 6 to 20% of the estimated dose of larvae injected could be recovered from nontransgenic hosts, whereas 75 to 95% of the estimated original inoculum was retained in air pouches in IL-5 transgenic mice (Fig. 7). Larval numbers in air pouch washings from transgenic hosts were not significantly reduced until 48 h after injection (P < 0.01), and even at this time, more than 45% of the estimated original inoculum was still recoverable.
|
| |
DISCUSSION |
|---|
|
|
|---|
We have previously demonstrated that IL-5 transgenic mice are very resistant to primary infections with the intestinal nematode N. brasiliensis. Relative to infections in their nontransgenic counterparts, few parasites complete migration to the small intestines of IL-5 transgenic mice (6, 7). This suggests that N. brasiliensis larvae are trapped and killed along the normal migratory route. In the present study we have analyzed the earlier lung and skin phases of infections with this parasite. The larval burden in the lungs of IL-5 transgenic mice was less than that in nontransgenic mice, and the time of arrival of larvae was delayed. It appeared, therefore, that larval entrapment in transgenic mice occurred within the first 24 h of infection and prior to arrival in the lungs. By 2 h p.i., leukocyte infiltrates were evident at the subcutaneous inoculation site in both host types. Larvae and high numbers of eosinophils were detected at the site of inoculation for at least 48 h in IL-5 transgenic mice, whereas in nontransgenic hosts larvae had mostly disseminated by 6 h p.i. When quantified in the air pouch model, most larvae had left the site of inoculation within 2 h of injection into nontransgenic hosts, and the involvement of eosinophils, although detectable, was always modest. In contrast, eosinophil recruitment and degranulation in IL-5 transgenic hosts occurred rapidly in air pouches injected with larvae, and few larvae migrated from this site within the first 32 h. Collectively these results suggest that in IL-5 transgenic mice, the majority of larvae are trapped and destroyed at the site of initiation of the primary infection. Such resistance has previously been clearly demonstrated only in secondary infections of nontransgenic mice. While eosinophils are prominent in secondary immune responses to this parasite (26), our very novel data suggest that most of the damage to N. brasiliensis larvae can occur before the development of parasite-specific humoral and cell-mediated immunity.
Following subcutaneous (or percutaneous) infection, N. brasiliensis L3 migrate to the lungs, where they are first evident approximately 15 h p.i. The larvae then molt before migrating by day 3 p.i. to the small intestine, via the trachea and esophagus (36, 37). Our data for nontransgenic mice are in keeping with these observations. In contrast, the arrival of larvae into the lungs of IL-5 transgenic mice was delayed, and at no stage did parasite numbers reach the levels detected in nontransgenic hosts. Both histological analysis and whole-tissue measurements of EPO suggest that eosinophil numbers increase in the lungs of nontransgenic mice over the course of infection. However, eosinophils were not prominent in histological sections of the lungs of these animals when sampled before 60 h p.i., even though peak larval numbers were recorded between 30 and 48 h p.i. It is significant, therefore, that EPO levels increased from as early as 24 h p.i. and remained elevated throughout this period. These data suggest that those few eosinophils present in the lungs at the same time as the parasite may have been more difficult to detect in histological sections because they had already degranulated. In contrast, over the first 24 to 48 h of infection, lungs recovered from transgenic mice showed little evidence of eosinophilic infiltrates or increased EPO activity, which is in keeping with our observation that the arrival of larvae is delayed. Eosinophil-rich infiltrates were detected from 60 h p.i., with some clearly focused on larvae. This suggests that some of the larvae which reach the lungs in IL-5 transgenic mice are trapped and killed there. Nevertheless, since few larvae ever reach the lungs in these mice, an appreciable level of entrapment and killing must occur elsewhere.
Associations between immunity to parasites and eosinophils within the skin of immunized animals have been demonstrated in studies with a variety of parasite species (23, 30, 37, 40). Immobilization of N. brasiliensis larvae occurs 2 to 3 h after penetration of the skin in mice immunized by prior infection (36). At the site of inoculation in both IL-5 transgenic and nontransgenic mice, we detected N. brasiliensis larvae which were surrounded by eosinophil-rich leukocyte infiltrates within 2 h of initiation of a primary infection. However, in nontransgenic mice, most larvae had disseminated from the skin by 6 h p.i. and the leukocyte accumulations were less evident from this time. Larval migration was even more rapid from air pouches in nontransgenic mice. A small but statistically significant increase in larval recovery from air pouches of nontransgenic mice was noted 4 to 12 h p.i., with moderate increases in eosinophil numbers and activity recorded for the same period. The developing inflammatory response within the air pouch or the surrounding environment may cause the detachment of some larvae from the air pouch wall, resulting in a transient rise in the number of larvae recovered by lavage of the air pouch. However, it is striking that in the IL-5 transgenic mice, the larvae do not attach firmly to the pouch wall at any time and few leave the pouch in the first 24 h p.i.
Detection of EPO within air pouch supernatants is significant not only because it suggests that eosinophils are activated and degranulating but also because EPO is toxic for a number of parasite species (1, 17, 25, 42). Other eosinophil granule proteins not analyzed in our study also have larvicidal properties (22, 41) and may be released at or around the same time as EPO. The extent of eosinophil degranulation, as indicated by the high levels of cell-free EPO detected in parasite-infected air pouches, also suggests that eosinophil numbers may have been underestimated. After the introduction of larvae, eosinophils are also very prominent in the wall of the air pouch in IL-5 transgenic mice, and these cells are not removed or quantitated with our lavage technique (unpublished data). Nevertheless, they may make a major contribution to containing the larvae within the pouch.
Air pouches have been used to great effect in analyzing inflammatory responses induced by a wide range of materials, including bacteria and protozoan parasites. A similar technique has also been used to assess inflammatory responses induced by eggs from the helminth Schistosoma mansoni (28). The work described above would appear to be the first published report of the use of the air pouch technique to study the inflammatory response induced by a skin-invasive stage of a helminth infection. It is particularly relevant for this application because it permits assessment of the inflammatory response in the skin itself, i.e., at or near the first point of contact of parasite and host. With this method, the extent of the cellular response can be estimated much more reliably and accurately than by quantitation of cells in histological sections of tissues recovered from the injection site. Where required, the extracellular fluid can also be analyzed. However, perhaps the greatest advantage of this approach is that the retention of larvae at the site of inoculation can be quantitated over an extended period and without the difficulties often inherent with alternative techniques requiring radioactive labelling of the parasite.
It is perhaps noteworthy that although a potent local inflammatory
response was detected in IL-5 transgenic mice after injection of
N. brasiliensis larvae into the skin (directly s.c. or into air pouches), there is no evidence of inordinate skin hypersensitivity or localized toxicity. The concentration of the EPO measured in this
study, and presumably of other components released from eosinophils, increased rapidly during the initial stages of the infection, but this
did not lead to overt tissue damage. Other experiments suggest that the
IL-5 transgenic mice (9) used in the present study are no
more sensitive to skin pathology than their wild-type counterparts.
Skin thickening after two exposures to the contact-sensitizing agent
trinitrochlorobenzene was similar in IL-5 transgenic mice and in
nontransgenic controls (unpublished results). Our IL-5 transgenic mice
were also similar to wild-type mice in terms of immediate
hypersensitivity reactions measured in two different assays
(unpublished results). In contrast, skin abnormalies or enhanced
hypersensitivity may be a feature of other IL-5 transgenic lines. Five
exposures to dinitrofluorobenzene causes dermatitis in another line of
IL-5 transgenic mice (38), and it is more severe than that
seen in similarly treated wild-type mice (24). In a third
line of IL-5 transgenic mice established by using a transgene driven by
the CD3
gene promoter/enhancer, ulcerating skin lesions and hair
loss occur spontaneously (20). Thus, under the conditions
that we have tested to date, marked skin pathology is not a feature of
our experimental model and extreme hypersensitivity does not appear to
be necessary for the primary resistance to N. brasiliensis
which we have described here. However, more frequent exposure to an
antigen, or the nature of the IL-5 transgene construct itself, may lead
to more severe skin lesions or toxicity which could prevent
dissemination of larvae via less physiological mechanisms. This should
be considered in any comparisons between different IL-5 transgenic
mouse models.
Eosinophils are probably not the only cell type active in the entrapment of N. brasiliensis larvae in this model, though we propose that their role is elemental to the process. For many hours after injection of larvae, neutrophils appear to be more numerous than eosinophils in air pouches in IL-5 transgenic mice. While this may be an artifact caused by the misidentification of eosinophils which have degranulated, unfortunately it is a difficult issue to resolve. There are no antibodies available to clearly differentiate mouse neutrophils and eosinophils on the basis of cell surface phenotype, and eosinophils lacking their characteristic granules could well be misclassified. However, in our IL-5 transgenic model, events vital to larval entrapment clearly occur within the first 2 h of infection. By this time, most larvae have migrated out of air pouches in nontransgenic mice, but this is not so in transgenic hosts. Neutrophil numbers in air pouches at this early stage of infection were approximately equal in the two hosts. In contrast, eosinophils were clearly far more numerous in transgenic than in nontransgenic hosts. Therefore, we propose that eosinophils rather than neutrophils are likely to be the critical factor in larval retention.
Although larvae may be trapped within the first few hours of infection, parasite killing probably proceeds at a relatively low rate since motile larvae can be recovered from air pouches for at least 48 h after inoculation (unpublished data). The decline in larval recovery after this time may reflect a combination of larval destruction and escape into other tissues. In support of the former, preliminary experiments in our laboratory have demonstrated immobilization of infective-stage larvae following 6 to 20 h of in vitro coculture with eosinophil-rich leukocytes from IL-5 transgenic mice (reference 5 and unpublished data). Larvae again become more motile after 24 h, coinciding with a precipitous decline in eosinophil viability. While eosinophils are recruited into the skin of nontransgenic mice early in infection, there may be insufficient numbers of these cells available in the tissue pool to significantly affect parasite migration. This view is generally supported by the size of infiltrates seen in histological sections and the numbers of leukocytes recovered from air pouches injected with larvae. On the other hand, IL-5 transgenic mice have an expanded pool of eosinophils which can be readily recruited to sites of antigenic challenge (32), and larvae in these hosts may eventually be overwhelmed by the early and qualitatively more appropriate inflammatory response at the site of inoculation.
Eosinophils in IL-5 transgenic mice may be activated by prolonged exposure to this cytokine, perhaps enhancing antilarval activity in mice infected with N. brasiliensis. Our earlier results suggest that if activation does occur, it does not appear to be excessive for a number of parameters assessed (6, 8). It is also worth noting that eosinophils from parasite-infected nontransgenic mice can be chronically exposed to levels of IL-5 comparable to those seen in uninfected IL-5 transgenic mice (9, 32). So, at least for the early stages of N. brasiliensis infection, the exposure of eosinophils to IL-5 in IL-5 transgenic animals is likely to be within normal physiological limits.
Eosinophils were usually closely associated with larvae seen in histological sections of tissue from the inoculation site. Mechanisms through which these cells may interact with and damage migrating larvae are not completely understood, but innate pattern recognition systems are likely to be involved in the initial steps. Complement, natural antibodies, and lectin receptors may all contribute, but further study of this issue is necessary. It is likely that eosinophil adherence to the parasite surface is an important trigger for the release of toxic granule proteins. Since EPO levels in the fluid phase of air pouch washings were maximal 4 h p.i., it is evident that eosinophils begin to degranulate soon after coming into contact with larvae. It is likely that eosinophil-derived neurotoxin, another eosinophil granule protein and potent neurotoxin, contributes to the initial immobilization of the larvae. This could be crucial in keeping the larvae in a state and location in which they are most susceptible to further immune attack.
To date, studies analyzing eosinophil associations with this and other parasites have shown dependence on the presence of parasite-specific antibody, either in vitro or in immunized animals (3, 4, 39). In direct contrast, the most important features of our study were that resistance was evident in IL-5 transgenic animals exposed to primary infections and that this occurred within the first 24 h of exposure to the parasite. From these very critical observations, we conclude that parasite-specific antibodies are not likely to be essential for the processes of eosinophil attachment, activation, and degranulation.
In summary, entrapment and/or killing of N. brasiliensis larvae may occur within the lungs of IL-5 transgenic mice, but our data suggest that the majority of larvae are eliminated at the site of inoculation. This process begins within a few hours of injection of larvae into naive animals and may be largely complete within the first 48 h of infection. Responses observed in IL-5 transgenic mice are similar in quality and initial time of onset to those detected in nontransgenic mice, but the magnitude and duration of the reactions are significantly greater in transgenic hosts. Though we cannot at this stage exclude other mechanisms induced by IL-5, eosinophils would appear to be responsible for the enhanced resistance observed in IL-5 transgenic mice. In more general terms, our data also suggest that animals with preexisting eosinophilia, induced by either previous or current exposure to parasites, may have an enhanced degree of innate resistance to primary infections with other helminth species. This adds a new dimension to the role of eosinophils in innate immunity and should encourage a reassessment of concurrent infections in experimental animals, with the focus now shifting to the earliest stages of exposure with the challenge parasite species.
Our results may have considerable significance to management in humans of diseases in which eosinophils are a prominent feature. The high levels of IL-5 and eosinophilia detected in uninfected IL-5 transgenic mice are seen not only in helminth-infected nontransgenic mice (9, 32) but also in humans infected with similar parasites (21). Eosinophilia occurs at very high frequency in human populations in some regions, most probably due to recent or ongoing parasite infections (35), and this may provide some protection against reinfection with helminths (15, 34), or even against infection with helminth species encountered for the first time. Field studies in several countries also suggest that humans with atopic diseases may be more resistant to helminth infections (13, 14), possibly in part due to priming of eosinophilopoiesis and enhanced activation and survival of eosinophils. Therapeutic measures designed to control asthma and allergic diseases by down-regulating eosinophils may therefore have the adverse effect of rendering patients more susceptible to acquisition or exacerbation of helminth infections. In particular, such treatments may impair at least partial protection afforded by a previously undervalued component of the innate immune response.
| |
ACKNOWLEDGMENTS |
|---|
Thanks go to Ann Hallett and Hans Scoppe for technical assistance, Leon Bignold for helpful discussions and assistance with histology, and Dale Caville for assistance with photography.
This work was supported in part by the Australian Research Council and the University of Adelaide Faculty of Medicine.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Immunology, The University of Adelaide, Adelaide, SA, Australia 5005. Phone: 61 8 8303 4155. Fax: 61 8 8303 4362. E-mail: lindsay.dent{at}adelaide.edu.au.
Editor: J. M. Mansfield
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bass, D. A., and P. Szejda. 1979. Mechanism of killing newborn larvae of T. spiralis by neutrophils and eosinophils. Killing by generators of hydrogen peroxide in vitro. J. Clin. Investig. 64:1558-1564. |
| 2. | Butterworth, A. E. 1984. Cell-mediated damage to helminths. Adv. Parasitol. 23:143-235[Medline]. |
| 3. | Butterworth, A. E., D. L. Wassom, G. J. Gleich, D. A. Loegering, and J. R. David. 1979. Damage to schistosomula of S. mansoni induced directly by eosinophil major basic protein. J. Immunol. 122:222-229. |
| 4. | Capron, A., J. P. Dessain, A. Haque, and M. Capron. 1982. Antibody-dependent cell-mediated cytotoxicity against parasites. Prog. Allergy 31:234-267[Medline]. |
| 5. | Daly, C. M., G. Mayrhofer, and L. A. Dent. 1998. Trapping and killing of N. brasiliensis larvae in IL-5 transgenic mice. Immunologist Suppl. 1:511. (Abstract). |
| 6. | Dent, L. A., C. Daly, A. Geddes, J. Cormie, D. A. Finlay, L. Bignold, P. Hagan, R. M. E. Parkhouse, T. Garate, J. Parsons, and G. Mayrhofer. 1997. Immune responses of IL-5 transgenic mice to parasites and aeroallergens. Mem. Inst. Oswaldo Cruz 92(Suppl. II):45-54. |
| 7. |
Dent, L. A.,
C. M. Daly,
G. Mayrhofer,
T. Zimmermann,
A. Hallett,
L. P. Bignold,
J. Creaney, and J. C. Parsons.
1999.
Interleukin-5 transgenic mice show enhanced resistance to primary infections with Nippostrongylus brasiliensis but not primary infections with Toxocara canis.
Infect. Immun.
67:989-993 |
| 8. | Dent, L. A., G. H. Munro, K. P. Piper, C. J. Sanderson, D. A. Finlay, R. K. Dempster, L. P. Bignold, D. G. Harkin, and P. Hagan. 1997. Eosinophilic interleukin 5 (IL-5) transgenic mice: eosinophil activity and impaired clearance of Schistosoma mansoni. Parasite Immunol. 19:291-300[Medline]. |
| 9. |
Dent, L. A.,
M. Strath,
A. L. Mellor, and C. J. Sanderson.
1990.
Eosinophilia in transgenic mice expressing interleukin 5.
J. Exp. Med.
172:1425-1431 |
| 10. | Dimayuga, E., M. Stober, and S. G. Kayes. 1991. Eosinophil peroxidase levels in hearts and lungs of mice infected with Toxocara canis. J. Parasitol. 77:461-466[Medline]. |
| 11. | Edwards, J. C. W., A. D. Sedgwick, and D. A. Willoughby. 1981. The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J. Pathol. 134:147-156[Medline]. |
| 12. | Gleich, G. J., and D. A. Loegering. 1984. Immunobiology of eosinophils. Annu. Rev. Immunol. 2:249-259. |
| 13. | Grove, D. I. 1982. What is the relationship between asthma and worms? Allergy 37:139[Medline]. |
| 14. | Grove, D. I., and I. J. Forbes. 1975. Increased resistance to helminth infestation in an atopic population. Med. J. Aust. 1:336-338[Medline]. |
| 15. | Hagan, P., H. A. Wilkins, U. J. Blumenthal, R. J. Hayes, and B. M. Greenwood. 1985. Eosinophilia and resistance to Schistosoma haematobium in man. Parasite Immunol. 7:625-631[Medline]. |
| 16. | Hamann, K. H., R. L. Barker, D. A. Loegering, and G. J. Gleich. 1987. Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis. J. Parasitol. 73146:523-529. |
| 17. | Jong, E. C., W. R. Henderson, and S. J. Klebanoff. 1980. Peroxidase mediated toxicity to schistosomula of Schistosoma mansoni. J. Immunol. 126:468-471[Abstract]. |
| 18. | Kassai, T. 1982. Handbook of Nippostrongylus brasiliensis (Nematode). Commonwealth Agricultural Bureaux, Slough, United Kingdom. |
| 19. | Kierszenbaum, F., S. J. Ackerman, and G. J. Gleich. 1981. Destruction of bloodstream forms of Trypanosoma cruzi by eosinophil granule major basic protein. Am. J. Trop. Med. Hyg. 30:775-779. |
| 20. | Lee, N. A., M. P. McGarry, K. A. Larson, M. A. Horton, A. B. Kristensen, and J. J. Lee. 1997. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J. Immunol. 158:1332-1344[Abstract]. |
| 21. |
Limaye, A. P.,
J. S. Abrams,
J. E. Silver,
E. A. Ottesen, and T. B. Nutman.
1990.
Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients.
J. Exp. Med.
172:399-402 |
| 22. | McLaren, D. J., C. E. Paterson, and P. Venge. 1984. Schistosoma mansoni: further studies of the interaction between schistosomula and granulocyte derived cationic proteins in vitro. Parasitology 88:491-503. |
| 23. | Moqbel, R. 1980. Histopathological changes following primary, secondary and repeated infection of rats with Strongyloides ratti, with special reference to eosinophils. Parasite Immunol. B2:11-27. |
| 24. |
Nagai, H.,
Y. Ueda,
H. Tanaka,
Y. Hirano,
N. Nakamura,
N. Inagaki,
K. Takatsu, and K. Kawada.
1999.
Effect of overproduction of interleukin 5 on dinitrofluorobenzene-induced allergic cutaneous response in mice.
J. Pharmacol. Exp. Ther.
288:43-50 |
| 25. | Nogueira, N. M., S. J. Klebanoff, and Z. A. Cohn. 1987. Trypanosoma cruzi: sensitisation to macrophage killing by EPO. J. Immunol. 128:1705-1708[Abstract]. |
| 26. | Ogilvie, B. M., and V. E. Jones. 1971. Nippostrongylus brasiliensis: a review of immunity and the host/parasite relationship in the rat. Exp. Parasitol. 29:138-177[Medline]. |
| 27. | Ornstein, L., H. Anstey, and A. Saunders. 1976. Improving manual differential white blood cell counts with cytochemistry. Blood Cells 2:557-561. |
| 28. | Pacheco, R. G., and H. L. Lenzi. 1997. Systemic modulation of peripheral eosinophilia (air pouch model) in Schistosoma mansoni infection. Mem. Inst. Oswaldo Cruz 92(Suppl. II):165-172. |
| 29. |
Patterson, K. G.,
D. C. Linch, and M. Rosendaal.
1981.
In situ cytoenzymatic identification of human bone marrow colonies grown in agar: a simple method with automated cytochemistry reagents.
J. Clin. Pathol.
34:935-938 |
| 30. | Rotman, H. L., W. Yutanawiboonchai, R. A. Brigandi, O. Leon, G. J. Gleich, T. J. Nolan, G. A. Schad, and D. Abraham. 1996. Strongyloides stercoralis-eosinophil-dependent immune-mediated killing of third stage larvae in Balb/CBYJ mice. Exp. Parasitol. 82:267-278[Medline]. |
| 31. | Sanderson, C. J., M. Strath, I. Mudway, and L. A. Dent. 1994. Transgenic experiments with interleukin-5, p. 335-351. In G. J. Gleich, and A. B. Kay (ed.), Eosinophils in allergy and inflammation. Marcel Dekker, Inc., New York, N.Y. |
| 32. | Strath, M., L. A. Dent, and C. J. Sanderson. 1992. Infection of IL-5 transgenic mice with Mesocestoides corti induces high levels of IL-5 but depressed production of eosinophils. Exp. Hematol. 120:229-234. |
| 33. | Strath, M., D. J. Warren, and C. J. Sanderson. 1985. Detection of eosinophils using an eosinophil peroxidase assay: its use as an assay for eosinophil differentiation factors. J. Immunol. Methods 83:209-215[Medline]. |
| 34. | Sturrock, R. F., R. Kimani, B. J. Cottrell, A. E. Butterworth, H. M. Seitz, T. K. Siongok, and V. Houba. 1983. Observations on possible immunity to reinfection among Kenyan schoolchildren after treatment for Schistosoma mansoni. Trans. R. Soc. Trop. Med. Hyg. 77:363-371[Medline]. |
| 35. | Supanaranond, W., S. Migasena, P. Pitisuttitham, and P. Suntharasamai. 1990. Health status of Thai volunteers in a cholera vaccine trial. J. Med. Assoc. Thailand 73:548-551[Medline]. |
| 36. | Taliaferro, W. H., and M. P. Sarles. 1939. The cellular reactions in the skin, lungs and intestine of normal and immune rats after infection with Nippostrongylus muris. J. Infect. Dis. 64:157-192. |
| 37. | Tindall, N. R., and P. A. G. Wilson. 1990. An extended proof of migration routes of immature parasites inside hosts: pathways of Nippostrongylus brasiliensis and Strongyloides ratti in the rat are mutually exclusive. Parasitology 100:281-288. |
| 38. |
Tominga, A.,
S. Yamauchi,
Y. Kanai,
J. I. Miyazaki,
G. Usuku,
K. I. Yamamura, and K. Takatsu.
1991.
Transgenic mice expressing a B cell growth and differentiation factor gene (IL-5) develop eosinophilia and auto-antibody production.
J. Exp. Med.
173:429-437 |
| 39. | Vadas, M. A., A. E. Butterworth, B. Sherry, A. Dessein, M. Hogan, D. Bout, and J. R. David. 1980. Interaction between human eosinophils and schistosomula of S. mansoni. I. Stable and irreversible antibody-dependent adherence. J. Immunol. 124:1441-1448[Medline]. |
| 40. | Ward, R. E., and R. J. McLaren. 1980. Schistosoma mansoni: evidence that eosinophils and/or macrophages contribute to skin-phase challenge attrition in vaccinated CBA/Ca mice. Parasitology 96:63-84. |
| 41. | Wassom, D. L., and G. J. Gleich. 1979. Damage to Trichinella spiralis new born larvae by eosinophil major basic protein. Am. J. Trop. Med. Hyg. 28:860-863. |
| 42. | Yoshimura, K., H. Sugaya, and K. Ishida. 1994. The role of eosinophils in Angiostrongylus cantonesis infection. Parasitol. Today 10:231-233. [Medline] |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»